News & Events about Senti Biosciences Inc.
SAN DIEGO, May 02, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of law in connection with the following special purpose acquisition companies ("SPACs") and whether investors' losses may be recovered under the federal securities laws. ...
Preclinical data supports SENTI-202 as a potential first-in-class logic gated CAR-NK cell therapy; remains on track for IND submission in 2H 2023 Additional data presented on SENTI-301A and crIL-15 support Sentis development of gene circuit enhanced CAR-NK programs for multiple cancer indications ...
SOUTH SAN FRANCISCO, Calif., April 14, 2023 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (Senti Bio), a biotechnology company innovating next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced its participation at the following investor ...
Globe Newswire
2 months ago
SAN DIEGO, March 29, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of law in connection with the following special purpose acquisition companies ("SPACs"): BigBear.ai Holdings, Inc. f/k/a GigCapital4 Inc. (NYSE: BBAI)Tango Therapeutics...
Globe Newswire
2 months ago
SAN DIEGO, March 09, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of law in connection with the following special purpose acquisition companies ("SPACs"): Advent Technologies Holdings, Inc. f/k/a AMCI Acquisition Corp (NASDAQ: ADN)...